A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
OPEN TO ACCRUAL
III
NCT05304585
bdenardo@BrownHealth.org
